← Back to Clinical Trials
Recruiting NCT06293235

NCT06293235 Towards Optimal Fertility, Fathering and Fatherhood studY

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06293235
Status Recruiting
Phase
Sponsor KK Women's and Children's Hospital
Condition Reproductive Issues
Study Type OBSERVATIONAL
Enrollment 960 participants
Start Date 2024-06-21
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 49 Years
Study Type OBSERVATIONAL
Interventions
Lifestyle and metabolic indicators

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 960 participants in total. It began in 2024-06-21 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This case-control study involving fertile and subfertile couples aims to identify male factors related to pregnancy likelihood, create a fertility index measure combining male and female factors to predict pregnancy likelihood, and examine how male factors relate to the semen physical and biological characteristics.

Eligibility Criteria

Inclusion Criteria: Subfertile couples: * men aged ≥21-49 years * men with a female partner aged 21-39 years * couples who are not able to conceive for at least 12 months * couples who are Singapore citizen or permanent resident Fertile couples: * men aged 21-49 years * men with a female partner aged 21-39 years * men with proven fertility defined as those female partners who are currently pregnant and with viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study * couples with attempted time to conceive within 12 months to achieve this pregnancy or with unplanned pregnancy * couples who are Singapore citizen or permanent resident Exclusion Criteria: Subfertile couples: * male infertility of a known aetiology including azoospermia, retrograde ejaculation, genetic disorders, cancer treatment, or testes trauma * female infertility diagnosis as confirmed by diagnostic imaging or having severe endometriosis * female partners with irregular menstrual cycle \>35 days * couples with known chromosomal abnormalities Fertile couples: * couples who achieve pregnancy after oocyte or spermatozoa donation * couples with known chromosomal abnormalities * female partners with known uterine abnormalities

Contact & Investigator

Central Contact

Benjarat Oh

✉ benjarat.oh@kkh.com.sg

📞 63948105

Principal Investigator

See Ling Loy, PhD

PRINCIPAL INVESTIGATOR

KK Women's and Children's Hospital

Frequently Asked Questions

Who can join the NCT06293235 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 49 Years, studying Reproductive Issues. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06293235 currently recruiting?

Yes, NCT06293235 is actively recruiting participants. Contact the research team at benjarat.oh@kkh.com.sg for enrollment information.

Where is the NCT06293235 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT06293235 clinical trial?

NCT06293235 is sponsored by KK Women's and Children's Hospital. The principal investigator is See Ling Loy, PhD at KK Women's and Children's Hospital. The trial plans to enroll 960 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology